European Industry Played Key Role In Mitigating COVID-19

Detailed Modelling And Industry Co-ordination Were Central To Managing Pandemic

In the first part of an exclusive two-part interview, James Burt – Accord’s executive vice-president for Europe, the Middle East and North Africa – talks to Generics Bulletin about the key actions taken by the generics industry to mitigate the coronavirus pandemic, and the changed landscape that the off-patent arena can expect to see in future.

Burt_James
Accord’s James Burt details the contributions made by the European generics industry to mitigating the COVID-19 pandemic • Source: Accord

The first half of 2020 has been defined by the outbreak of COVID-19. And with the coronavirus pandemic likely to continue to cast a long shadow, uncertainties within the off-patent industry and medicines sector as a whole persist.

Accord Healthcare has been among those firms at the heart of European efforts to fight the pandemic through concerted generics...

Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

More from Strategy

More from Business